These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. DNA probes. Fruits of the new biotechnology. Young FE JAMA; 1987 Nov; 258(17):2404-6. PubMed ID: 3118062 [TBL] [Abstract][Full Text] [Related]
23. Memo to FDA head: IT upgrade required. Nat Biotechnol; 2005 May; 23(5):507. PubMed ID: 15877051 [No Abstract] [Full Text] [Related]
24. Is the drought over for pharming? Kaiser J Science; 2008 Apr; 320(5875):473-5. PubMed ID: 18436771 [No Abstract] [Full Text] [Related]
25. The biotechnology revolution and its regulatory evolution. Hoffman DE Drake Law Rev; 1988-1989; 38(3):471-550. PubMed ID: 16086466 [No Abstract] [Full Text] [Related]
28. One hundred years of drug regulation: where do we go from here? Woosley RL Annu Rev Pharmacol Toxicol; 2013; 53():255-73. PubMed ID: 23072378 [TBL] [Abstract][Full Text] [Related]
29. Biotechnology: a selective survey. Goldsby RA Avian Dis; 1986; 30(1):3-11. PubMed ID: 3460566 [TBL] [Abstract][Full Text] [Related]
30. Testimony of the Industrial Biotechnology Association before the Subcommittees on Natural Resources, Agriculture Research and Environment; Science, Research and Technology; and Investigations and Oversight of the Committee on Science and Technology, House of Representatives, July 23, 1986. Godown R Recomb DNA Tech Bull; 1986 Sep; 9(3):203-10. PubMed ID: 3786832 [No Abstract] [Full Text] [Related]
31. New FDA appointment offers food for thought. Miller H Nat Biotechnol; 1998 Oct; 16(10):886. PubMed ID: 9788324 [No Abstract] [Full Text] [Related]
32. The ethics of biotechnology. Lenoir N J Biolaw Bus; 2000; Suppl.():111-5. PubMed ID: 12739544 [No Abstract] [Full Text] [Related]
33. Delegations of authority and organization; Center for Devices and Radiological Health--FDA. Final rule. Fed Regist; 1991 Oct; 56(197):51169-70. PubMed ID: 10115059 [TBL] [Abstract][Full Text] [Related]
34. The FDA's regulation of biotechnology: an activist approach. Miller HI; Young FE Bioessays; 1988 Nov; 9(5):178-9. PubMed ID: 3240311 [No Abstract] [Full Text] [Related]
35. Food biotechnology's challenge to cultural integrity and individual consent. Thompson PB Hastings Cent Rep; 1997; 27(4):34-8. PubMed ID: 9271720 [TBL] [Abstract][Full Text] [Related]
36. FDA scrutinizes human stem cell therapies. Fox JL Nat Biotechnol; 2008 Jun; 26(6):598-9. PubMed ID: 18536668 [No Abstract] [Full Text] [Related]
37. Biotechnology-a sustainable alternative for chemical industry. Gavrilescu M; Chisti Y Biotechnol Adv; 2005 Nov; 23(7-8):471-99. PubMed ID: 15919172 [TBL] [Abstract][Full Text] [Related]
38. The history and contemporary challenges of the US Food and Drug Administration. Borchers AT; Hagie F; Keen CL; Gershwin ME Clin Ther; 2007 Jan; 29(1):1-16. PubMed ID: 17379043 [TBL] [Abstract][Full Text] [Related]
39. The FDA's new oncology office. Pazdur R Clin Adv Hematol Oncol; 2005 Aug; 3(8):612-3. PubMed ID: 16167044 [No Abstract] [Full Text] [Related]
40. New rules for new drugs: the challenge of AIDS to the regulatory process. Edgar H; Rothman DJ Milbank Q; 1990; 68(Suppl. 1):111-42. PubMed ID: 11650413 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]